Barnes v. American Tobacco Co.

176 F.R.D. 479, 1997 U.S. Dist. LEXIS 12814, 1997 WL 550650
CourtDistrict Court, E.D. Pennsylvania
DecidedAugust 22, 1997
DocketCiv. A. No. 96-5903
StatusPublished
Cited by29 cases

This text of 176 F.R.D. 479 (Barnes v. American Tobacco Co.) is published on Counsel Stack Legal Research, covering District Court, E.D. Pennsylvania primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Barnes v. American Tobacco Co., 176 F.R.D. 479, 1997 U.S. Dist. LEXIS 12814, 1997 WL 550650 (E.D. Pa. 1997).

Opinion

MEMORANDUM

NEWCOMER, District Judge.

Presently before this Court are plaintiffs’ Renewed Motion for Certification of Medical Monitoring Class Pursuant to Fed.R.Civ.P. 23(b)(2), and defendants’ response thereto, and plaintiffs’ reply thereto, and defendants’ sur reply thereto, and the plaintiffs’ response to defendants’ sur reply thereto, and the various exhibits in support of the aforementioned. For the following reasons, the Court grants plaintiffs’ motion.

I. Introduction

On June 3, 1997, this Court entered an order and opinion in which plaintiffs’ motion for class certification was denied. Arch v. American Tobacco Co., 175 F.R.D. 469 (E.D.Pa.1997). Plaintiffs’ motion for class certification sought certification of the First Amended Complaint which contained the following causes of action: (1) medical monitoring; (2) intentional exposure to a hazardous substance; (3) negligence; and (4) strict products liability. Count five of plaintiffs’ First Amended Complaint averred that defendants acted in concert, or pursuant to a common design.

Plaintiffs sought certification of the following class under the First Amended Complaint:

All current residents of Pennsylvania who are cigarette smokers as of December 1, 1996, and who began smoking before age 19, while they were residents of Pennsylvania.

Plaintiffs argued that the general requirements of Fed.R.Civ.P. 23(a)(l)-(4) were satisfied and that class certification was proper under Fed.R.Civ.P. 23(b)(3) in the first instance. In addition, plaintiffs contended that their medical monitoring claim could be properly certified under Fed.R.Civ.P. 23(b)(2). Alternatively, plaintiffs sought issue certification under Fed.R.Civ.P. 23(c)(4).

Plaintiffs’ motion for certification was denied. Plaintiffs’ claims were found not to be [482]*482certifiable under Rule 23(b)(3) because plaintiffs could not satisfy the superiority and predominance requirements. Additionally, plaintiffs’ request for certification of their medical monitoring claim was denied because the majority of relief sought by plaintiffs was predominantly compensatory as opposed to equitable. Finally, the Court denied issue certification under Rule 23(c)(4).

Subsequent to the Court’s June 3, 1997 order and opinion, plaintiffs filed a motion for leave to file a Second Amended Complaint, along with a renewed motion for class certification. Plaintiffs’ Second Amended Complaint, which plaintiffs were granted leave to file, is significantly different from plaintiffs prior two complaints in this action. In their Second Amended Complaint, plaintiffs1 maintain only one claim against the defendants 2 — a claim for medical monitoring. Plaintiffs have discarded their claims sounding in negligence, strict products liability and intentional exposure to a hazardous substance.

In support of their medical monitoring claim, plaintiffs set forth the following facts in their Second Amended Complaint. Plaintiffs allege that defendants manufacture, promote and sell cigarettes. Defendants’ earnings on cigarettes sold throughout the United States allegedly exceeded six billion dollars this past year alone, on gross sales of forty-five billion dollars. According to the Pennsylvania Department of Health, more than 22.6 billion cigarettes were sold in Pennsylvania during the fiscal year July 1995 through June 1996.

Plaintiffs allege that cigarettes contain hazardous substances that cause serious and often fatal diseases of the throat, lungs, and heart, as well as the cardiovascular and pulmonary systems generally, and cause stillbirths and neonatal deaths of babies whose mothers smoke. The hazardous substances include, inter alia, nicotine, carbon monoxide, nitrosamine, formaldehyde, formic acid, acetaldehyde, ammonia, benzene, hydrogen cyanide, and “tar,” which are all highly dangerous substances.

Plaintiffs maintain that defendants, acting in concert or pursuant to a common design, have engaged in a wide range of conduct for which they should be held liable to plaintiffs. Defendants allegedly have known of the relationship between cigarettes and disease but have concealed their research, publicly denied the relationship between cigarettes and disease, and continue to aggressively promote and sell cigarettes. In so doing, plaintiffs contend that defendants have engaged in this conduct not only with willful, wanton and reckless disregard for the health of those who use their products, “but have intentionally and deliberately consigned millions of users to disease and death, for no reason other than to maximize [their] profits.” (Second Amended Compl. ¶ 12). Further, it is alleged that these defendants have known for many years of ways to make safer cigarettes but have intentionally chosen not to do so.

Defendants have also purportedly known for many years that nicotine is addictive but have publicly denied both the fact that nicotine is addictive and their knowledge of this fact. During the same time that defendants have publicly denied the addictive nature of nicotine, it is alleged that defendants have intentionally controlled the level of nicotine and other toxic substances in the cigarettes in order to preserve the dependence of smokers on cigarettes. Plaintiffs aver that defendants have utilized additives such as ammonia, as well as designs for which de[483]*483fendants have sought patents, to make cigarettes a “package” for the delivery of nicotine. During this same period of time, plaintiffs allege that defendants have also intentionally avoided researching or developing cigarettes that would not cause dependence or addiction in those who use them.

In order to preserve and increase their sales of cigarettes, and despite their knowledge of the diseases and harm that cigarettes cause, it is alleged that defendants have spent millions of dollars each year in advertising and promoting cigarettes and have geared their efforts particularly to teenagers and children through such efforts as the “Joe Camel” advertising campaign because defendants have allegedly known that unless a person begins smoking before the age of twenty, the person is unlikely to ever begin.

Plaintiffs further allege that in their efforts to conceal the health hazards of smoking and the addictive nature of nicotine, defendants have testified falsely under oath before the United States Congress, provided false explanations to customers and governmental entities about the health hazards of tobacco and the harmful quantities of nicotine, concealed their secret research and testing on the dangers of cigarette smoking, concealed their deliberate manipulation of nicotine levels of cigarettes, required employees, under threat of severe legal sanctions, to keep secret all information that they have learned through their employment about the dangers of cigarette smoking, and concealed documents through devices such as the unwarranted invocation of the attorney client privilege.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

DAVIS v. TARGET CORPORATION
E.D. Pennsylvania, 2025
Agostino v. Quest Diagnostics Inc.
256 F.R.D. 437 (D. New Jersey, 2009)
In re Welding Fume Products Liability Litigation
245 F.R.D. 279 (N.D. Ohio, 2007)
In re Unumprovident Corp. Erisa Benefits Denial Actions
245 F.R.D. 317 (E.D. Tennessee, 2007)
Hohider v. United Parcel Service, Inc.
243 F.R.D. 147 (W.D. Pennsylvania, 2007)
Gartin v. S & M NuTec LLC
245 F.R.D. 429 (C.D. California, 2007)
Blain v. Smithkline Beecham Corp.
240 F.R.D. 179 (E.D. Pennsylvania, 2007)
In re Prempro Products Liability Litigation
230 F.R.D. 555 (E.D. Arkansas, 2005)
Spain v. Brown & Williamson Tobacco Corp.
872 So. 2d 101 (Supreme Court of Alabama, 2003)
Wall v. Sunoco, Inc.
211 F.R.D. 272 (M.D. Pennsylvania, 2002)
In re Linerboard Antitrust Litigation
203 F.R.D. 197 (E.D. Pennsylvania, 2001)
Osgood v. Harrah's Entertainment, Inc.
202 F.R.D. 115 (D. New Jersey, 2001)
In re Resources America Securities Litigation
202 F.R.D. 177 (E.D. Pennsylvania, 2001)
Flannick v. First Union Home Equity Bank
134 F. Supp. 2d 389 (E.D. Pennsylvania, 2001)
Philip Morris Inc. v. Angeletti
752 A.2d 200 (Court of Appeals of Maryland, 2000)
Clay v. American Tobacco Co.
188 F.R.D. 483 (S.D. Illinois, 1999)
Emig v. American Tobacco Co.
184 F.R.D. 379 (D. Kansas, 1998)

Cite This Page — Counsel Stack

Bluebook (online)
176 F.R.D. 479, 1997 U.S. Dist. LEXIS 12814, 1997 WL 550650, Counsel Stack Legal Research, https://law.counselstack.com/opinion/barnes-v-american-tobacco-co-paed-1997.